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Abstract
Higher dietary intakes of saturated fatty acid increase the risk of developing Alzheimer’s disease and dementia, and
even in people without diabetes higher glucose levels may be a risk factor for dementia. The mechanisms causing
neuronal dysfunction and dementia by consuming high-fat diet degrading the integrity of the blood-brain barrier
(BBB) has been suggested but are not yet fully understood, and metabolic state of the brain by this type of insult is
still veiled. The objective of this study was to investigate the effect of high-fat diet on the brain metabolism by a
multimodal imaging method using the hyperpolarizedcarbon 13 (13C)-pyruvate magnetic resonance (MR)
spectroscopy and dynamic contrast-enhanced MR imaging in conjunction with the biochemical assay and the
behavior test in a mouse model fed high-fat diet (HFD). In mice were fed 60% HFD for 6 months, hyperpolarized
[1-13C] pyruvate MR spectroscopy showed decreased perfusion (p < 0.01) and increased conversion from pyruvate
to lactate (p < 0.001) in the brain. The hippocampus and striatum showed the highest conversion ratio. The
functional integrity of the blood-brain barrier tested by dynamic contrast-enhanced MR imaging showed no
difference to the control. Lactate was increased in the cortex (p < 0.01) and striatum (p < 0.05), while PDH activity
was decreased in the cortex (p < 0.01) and striatum (p < 0.001) and the phosphorylated PDH was increased in the
striatum (p < 0.05). Mice fed HFD showed less efficiency in learning memory compared with control (p < 0.05). To
determine whether hyperpolarized 13C-pyruvate magnetic resonance (MR) spectroscopy could detect a much earier
event in the brain. Mice fed HFD for 3 months did not show a detectable cognitive decline in water maze based
learning memory. Hyperpolarized [1-13C] pyruvate MR spectroscopy showed increased lactate conversion (P < .001), but
no difference in cerebral perfusion. These results suggest that the increased hyperpolarized [1-13C] lactate signal in the
brain of HFD-fed mice represent that altered metabolic alteration toward to glycolysis and hypoperfusion by the long-
term metabolic stress by HFD further promote to glycolysis. The hyperpolarized [1-13C] pyruvate MR spectroscopy can
be used to monitor the brain metabolism and will provide information helpful to understand the disease process.
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Introduction
The metabolic disorder has been suggested as a risk fac-
tor to induce cognitive decline and dementia. Moreover,
higher dietary intakes of saturated fatty acid increase the
risk of developing Alzheimer’s disease and dementia [1,
2]. Patients with diabetes have two-fold risk to develop
Alzheimer’s disease and also shorten the conversion time
from preclinical to mild cognitive impairment [3, 4].
Interestingly, people with hyperglycemia without
diabetes also showed a positive correlation with the cog-
nitive decline and dementia [5, 6]. The mechanisms
causing neuronal dysfunction and dementia have been
suggested that reduced the tight junction proteins by el-
evated circulating amyloid-β levels [7] or by inflamma-
tion [8], but are not yet fully understood. And the
impairment of insulin homeostasis in diabetes has been
suggested to accelerate susceptibility to Alzheimer’s dis-
ease [9] by activating glycogen synthesis kinase-3, a kin-
ase for tau protein, promote neurofibrillary tangle and
beta-amyloid production [10, 11]. But the metabolic
state of the brain affected by this type of insult is still
veiled and imaging method to quantitatively present the
metabolic information in the brain at the earlier process
related to cognitive decline and dementia is needed.
A Fluorine 18 (18F) fluorodeoxyglucose (FDG) positron
emission tomography (PET) study in Alzheimer’s disease
reported decreased cerebral glucose metabolism along
with amyloid-β accumulation using the 11C-Pittsburgh
compound B PET imaging [12]. A decreased state of
glucose metabolism was thought to be an early marker
of dementia before diagnosed with cortical atrophy or
clinical symptoms [13]. On the other hand, spatial corre-
lations between the sites of active aerobic activity in
young adults and those of beta-amyloid deposits in the
elderly have been reported by Pittsburgh compound B
and FDG-PET imaging studies [14]. Therefore, it is un-
clear whether any abnormal glucose metabolism affects
the early stages of cognitive impairment. An FDG-PET
study of Alzheimer’s disease showed 89% diagnostic ac-
curacy in the reduction of the cerebral metabolic rate in
the brain [15]. However, serum glucose levels above 160
mg/dL limit the use of brain 18F-FDG, and a systematic
review has shown that standardized uptake value in the
brain is inversely proportional to glycemia [16, 17].
Therefore, it is necessary to have an imaging method
that can observe the metabolism in the brain without
being affected by blood sugar.
Hyperpolarized carbon 13 (13C) magnetic resonance
(MR) spectroscopy can detect in vivo metabolism by
10,000-fold increased sensitivity using 13C enriched en-
dogenous metabolic substrates without being exposed to
ionizing irradiation [18, 19]. Hyperpolarized [1-13C]
pyruvate MR spectroscopy can detect [1-13C] lactate cat-
alyzed by lactate dehydrogenase (LDH), 13C-alanine by
alanine aminotransferase, and 13C bicarbonate by pyru-
vate dehydrogenase (PDH) [20]. The purpose of the
present study was to assess the brain metabolism by
using multimodal imaging method including hyperpolar-
ized [1-13C] pyruvate MR spectroscopy in conjunction
with the biochemical assay and the behavior test in a
cognitivelyimpaired a mouse model fed a high-fat diet
(HFD).
Material and methods
Animal procedures
Male ICR mice (30–35 g, seven weeks-old) were pur-
chased from Japan SLC, a branch of Charles River La-
boratories (Shizuoka, Japan). Mice were fed either a
normal diet (ND, 5053, PicoLab, 13.1 kcal % fat; control
mice) or High Fat diet (HFD, D12492, Research Diet
INC., Fat 54.3% kcal of lard, 5.6 kcal of soybean oil) for
12 weeks and 24 weeks (Table 1). The experimental
schedule of 12 weeks and 24 weeks were represented in
Fig. 1a and 7a, respectively.
All animal procedures were carried out according to
the protocol approved by the International Animal Care
and Use Committee (IACUC) of the Yonsei University
Animal Research Center (YLARC, permission No.
2015–0039) following NIH guidelines. All animals were
maintained in a specific pathogen-free facility of the
YLARC with well controlled temperature (23 °C) and
Light cycle (12 h light and 12 h dark) and easy access to
water and food.
Determination of body weight and serum glucose levels
Body weight (BW) and fasting serum glucose levels of all
animals were monitored. To measure fasting glucose
levels, mice fasted for 4 h before the test. Blood glucose
concentrations from blood samples taken from the tip of
the tail were measured using a glucometer. The body
weight and glucose levels were performed every 4 weeks.
Intraperitoneal glucose tolerance test (IPGTT)
Glucose tolerance test is a widely used to diagnose glu-
cose intolerance in obesity and type II diabetes mellitus
[21, 22]. The intraperitoneal glucose tolerance test was
performed at 24 weeks after high fat diet. Food was re-
moved a night before the test. The mice were injected
with glucose (1 g/kg/ip, dissolved in saline) in the morn-
ing. Blood glucose levels from blood samples taken from
the tail vein were measured using a glucometer at 0, 30,
60, and 120 min after the bolus [11].
Intraperitoneal insulin tolerance test (IPITT)
The intraperitoneal insulin tolerance test was performed
three days later after finishing IPGTT at 24 weeks after
high fat diet. Mice fasted for 4 h before the test. The
mice were injected with human recombinant insulin
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(0.75 unit/kg/ip, dissolved in saline). Blood glucose levels
from blood samples taken from the tail vein were mea-
sured using a glucometer at 0, 30, 60, and 120 min after
the bolus [11].
Serum insulin ELISA
The serum insulin ELISA test was performed at 24
weeks after high fat diet. Mice were sacrificed and the
blood was collected through cardiac puncture for
EDTA-plasma preparation. Serum insulin was measured
using an insulin ELISA kit (ALPCO, Windham, NH,
USA). 10 μL of each standard and control samples were
loaded into appropriate wells. Then, 75 μL of enzyme
conjugate (mouse monoclonal anti-insulin conjugated to
biotin) was added to each well and incubated for 2 h at
room temperature on the microplate shaker at 800 rpm.
After washing the microplate six times with 350 μL of
wash buffer, 100 μL of substrate solution, tetramethyl-
benzidine, was added to each well and incubated for 15
min at room temperature on the microplate shaker. The
enzymatic reaction was stopped by adding 100 μL of
stop solution to each well, and the absorbance was mea-
sured at 450 nm using a microplate reader.
Hyperpolarized 13C MR spectroscopy
We used 26.7 mg of [1-13C] pyruvic acid (Cambridge
Isotope, Tewksbury, MA) mixed with 15mM trityl rad-
ical OX-063 (Oxford Instruments, Oxford, UK) and 0.75
mM gadoteratemeglumine (Dotarem®, Guerbet, France)
for hyperpolarized 13C MRS. We hyperpolarized the
sample using a dynamic nuclear polarization system
(HyperSense®, Oxford Instruments, Oxford, UK) and dis-
solved it with 3.8 mL of Tris/EDTA-NaOH buffer, result-
ing in 79 mM pyruvate (pH 7.5) with a polarized level of
approximately 20%. We drew 350 μL of hyperpolarized
[1-13C] pyruvate into a syringe for in vivo MR
spectroscopy.
We performed in vivo hyperpolarized MR spectros-
copy using a 9.4 T animal imaging system (BioSpec 94/
20, Bruker BioSpin MRI GmbH, Ettlingen, Germany)
with a 1H-13C dual-tuned surface transmit/receive coil.
We acquired time-resolved 13C free induction decay data
from 7.5 mm axial slices of the whole brain with a flip
angle of 10° and time resolution of 1 s by using a
pulse-and-acquire sequence [23]. For the mapping of
metabolites, a single time point hyperpolarized 13C free
induction decay chemical shift image was obtained using
centric-ordered phase encoding with a flip angle of 10°
from 3.5 mm coronal slices of the brain using a 13C sin-
gle tune mouse head coil. Field of view was 18 × 24mm2
with a matrix size of 18 × 24 or 9 × 12. We produced a
Table 1 Diet composition
Normal diet High-fat diet
Protein (kcal %) 24.5 20
Carbohydrate (kcal %) 62.4 20
Fat (kcal %) 13.1 60
Rodent Diet with 60 kcal% Fat (D12492, Research Diets INC,.) Protein: 20% kcal;
Protein (Casein, Lactic, 30 Mesh), Protein (Cystine, L), Fat: 60% kcal; Fat (Lard),
Fat (Soybean Oil, USP), Carbohydrate: 20% kcal; Carbohydrate (Lodex 10),
Carbohydrate (Sucrose, Fine Granulated), Fiber (Solka Floc, FCC200), Mineral
(S10026B), Vitamin (Choline Bitartrate, V10001C), Dye (Blue FD&C #1, Alum.
Lake 35 ~ 42%), Energy Density: 5.21 kcal/g
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Fig. 1 High-fat diet (HFD) fed mice gained weight and presented hyperglycemia. (a) Experimental schedule. (b) Body weight was measured
every 4 weeks on each diet group. (c) Fasting serum glucose level. (d) Glucose tolerance test. (e) Insulin tolerance test. (f) Serum insulin level
measured using ELISA in the 24th week of the diet (p = 0.074). The p-values were obtained from the two-tailed Student’s t-test between HFD-fed
mice and control groups (n = 10 for both groups) *** p < 0.001. Abbreviation: BW = body weight; GL = serum glucose level; NOR = novel object
recognition test; MWM=water maze behavior test; 13C MRS = 13C magnetic resonance spectroscopy; 13C CSI = 13C chemical shift image; DCE-MRI
= dynamic contrast-enhanced magnetic resonance imaging
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hyperpolarized 13C metabolite map by measuring the
peak value of each metabolite and overlaid it on the pro-
ton T2 weighted image. The images were acquired for
35 s from 18 s after intravenous injection of pyruvate. All
data were processed using MATLAB-based analysis
(R2017a, MathWorks, Natick, MA, USA).
Dynamic contrast-enhanced MR imaging
We performed dynamic contrast-enhanced MR imaging
on a 3 T system (Discovery™ MR750, GE Healthcare, WI,
USA) to evaluate the integrity of the blood-brain barrier
function [24]. Pre- and post-contrast T1-weighted im-
ages were acquired by injecting 0.2 mmol/kg gadoterate-
meglumine (Doctarem®, Guerbet, Villepinte, France) into
the tail vein. Data were transferred to a workstation and
analyzed using GenIQ software (GE Medical Systems,
WI, USA).
Cognitive function test
We performed a Morris water maze test and object-loca-
tion memory test to evaluate the cognitive function as
previously described [25]. Briefly, the Morris water maze
test measured the time required to reach the hidden
platform and escape-latency in a circular pool 90 cm in
diameter and 30 cm in depth. The pool has quadrants by
four different visual cues, and a hidden platform 12 cm
in diameter submerged 2 cm below the black water sur-
face in one of the quadrants. In location memory task,
the experiment was performed in a black, rectangular,
acrylic open field box (25 cm sides) with 3-dimensional
plastic visual cue placed on the edge of the area. Mice
were allowed to explore the open field box with no ob-
jects but internal cue on one of the walls for 10 min for
two consecutive days. Twenty-four hours later, the trial
was performed. Two identical plastic objects were placed
in two opposite corner of the internal cue wall, where
the mice were allowed to freely explore the objects for
10 min. Another twenty-four hours later, the test was
performed in the same box, where one of the objects
was moved to the novel location of the arena. The
movements of the mice were video-recorded for 5 min.
All objects and arena were cleaned using 30% Ethanol
between every trial. Time spent for touching the objects
using nose was measured (T novel: time spent for touch-
ing the object placed in the novel location; T familiar:
time spent on touching the object to the familiar loca-
tion). Preference for the object displaced to the novel lo-
cation was calculated as the percent time.
Discrimination index was calculated with the formula-
tion of [(Tnovel– Tfamiliar)/(Tnovel + Tfamiliar)].Video re-
cording was performed using an Ethovision system
(Noldus, Wageningen, The Netherlands).
Assessment of PDH activity
PDH activity was measured using an assay kit (Abcam,
Cambridge, UK). Samples (200 μL) were incubated for 3
h at room temperature. The microplate was washed
twice with 300 μL of stabilizer, and then 200 μL of assay
solution was added. The absorbance of each well was
measured at 450 nm using a kinetic program for 15 min
with a microplate reader.
Assessment of lactate level
Lactate levels were measured using the L-Lactate assay
kit (Abcam, Cambridge, UK). Extracted blood from the
euthanized mice was centrifuged at 15,000 g for 5 min at
4 °C to separate serum. Tissue samples were harvested
and lysed using an NP-40 buffer. After measuring
BCA-based protein concentration, 40 μg of lysate was
used to detect lactate concentration. The absorbance
was measured at 450 nm according to the manufac-
turer’s protocol.
Western blot analysis
The collected hippocampal, neocortical and striatal tis-
sues were homogenized in ice-chilled 20 mM pH
7.4Tris-HCl buffer. Homogenate containing 15 μg of
protein was subjected to 8% SDS-PAGE under reducing
conditions. The proteins were transferred to PVDF
membranes in transfer buffer and then separated at 400
mA for 2 h at 4 °C. The Western blots were subsequently
incubated for 2 h with 5% skim milk at room
temperature and then incubated overnight with a 1:1000
dilution of anti-LDHA (NBP1–48336; NovusBio, CO,
USA), anti-β-actin (sc-47,778; Santa Cruz Biotechnology,
TX, USA), anti-LDHB (AB85319; Abcam, Cambridge,
UK), anti-claudin5 (ab-15,106; Abcam, Cambridge, UK),
anti-p-PDH (ab-92,696; Abcam, Cambridge, UK) and
anti-PDH antibodies (9H9AF5; The Thermo Fisher Sci-
entific, MA, USA). Then, the blots were washed twice
with Tween 20/Tris-buffered saline (TTBS) and
incubated with a 1:3000 dilution of horseradish
peroxidase-conjugated secondary antibody for 2 h at
room temperature. After washing 3 times with TTBS,
blots were developed using enhanced chemilumines-
cence (Amersham Life Science, Arlington Heights, IL,
USA). The membranes were analyzed using the Multi
Gauge bioimaging program on the Las-4000 mini (Fuji-
film Life Science USA, Stamford, CT, USA).
Statistical analysis
Data were analyzed using a one-way analysis of variance
(ANOVA) followed by Newman-Keuls test for post-hoc
comparisons. Student’s t-test was used to compare the
two groups. In the behavioral study, data were analyzed
using a two-way ANOVA followed by Bonferroni’s test
for post-hoc comparisons. Dynamic conversion ratio was
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analyzed using a linear mixed model with random ana-
lysis. All results were expressed as a mean ± standard
error of the mean, and p < 0.05 was considered statisti-
cally significant. Statistical analysis was performed by
using statistical software (PRISM version 6.0, GraphPad
Software, CA, USA; SPSS 23, SPSS Inc., IL, USA).
Results
Mice fed HFD for 6months showed higher lactate
conversion in hyperpolarized 13C MRS
Mice fed HFD for 24 weeks showed hyperglycemic state
with weight gain represented by an increased fasting glu-
cose level when compared with normal diet fed mice.
However, no difference was observed in the glucose tol-
erance test, insulin tolerance test, and serum insulin
level (n = 10 for both groups; p < 0.001; Fig. 1b-f ). We
have investigated the metabolic influence of the hyper-
glycemic state in the brain of 24 weeks after HFD fed
mice using by the hyperpolarized 13C MR spectroscopy.
Which were detected [1-13C] pyruvate at 173 ppm, and
[1-13C] lactate at 185 ppm in the brain of control (Fig. 2a)
and HFD-fed mice (Fig. 2b). The dynamic conversion ra-
tio of hyperpolarized [1-13C] lactate/[1-13C] pyruvate
calculated from the peak intensities of the MR spectrum
showed significantly increased lactate conversion in the
brain of HFD-fed mice (n = 5 for both groups, p <
0.0001; Fig. 2c). HFD-fed mice showed significantly
decreased total 13C signal in the brain, which repre-
sents perfusion, calculated by the sum of the area
under the spectrum for 10 s from the injection (41.4
± 7.6 vs. 28.8 ± 4.28 × 107, respectively; n = 5 for both
groups; p < 0.01; Fig. 2d). Hyperpolarized [1-13C] lac-
tate/[1-13C] pyruvate ratio showed a negative correl-
ation with total 13C signal (Fig. 2e; n = 10, Pearson’s r
= − 0.632, p < 0.05). [1-13C] pyruvate could estimate
the mitochondrial metabolism, because pyruvate con-
verted to acetyl Co-A and CO2 by PDH in the mito-
chondria. Therefore, hyperpolarized 13C bicarbonate,
in equilibrium with CO2, directly reflects the TCA
cycle rate [26]. To evaluate metabolic preference be-
tween cytoplasmic glycolysis and mitochondrial oxida-
tion, we analyzed [1-13C] lactate/13C-bicarbonate
ratio. Hyperpolarized [1-13C] lactate/13C-bicarbonate
ratio was increased in HFD-fed mice (n = 5, for both
groups, P < 0.05; Fig. 2f ).
Rate constants converting pyruvate to lactate (KP) by
lactate dehydrogenase (LDH) catalyzed reaction was cal-
culated by fitting the peak intensities of pyruvate and
lactate to the modified Bloch equations for two-site ex-
change as previously described [27]. KP for control and
HFD-fed mice were 0.021 ± 0.009 and 0.056 ± 0.015, re-
spectively. These results represented that brain metabol-
ism in the mice fed HFD activated cytosolic glycolysis in
the mice fed HFD for 6 months.
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Fig. 2 HFD-fed mice showed increased lactate signal and decreased brain perfusion in hyperpolarized 13C magnetic resonance (MR)
spectroscopy. A, B, The stack plot of sequential spectra collected every second displayed for 90 s of the hyperpolarized 13C MR spectrum shows
[1-13C] pyruvate at 173 ppm and [1-13C] lactate at 185 ppm in the brain of control (a) and HFD-fed mice (b). (c) The dynamic conversion ratio of
hyperpolarized [1-13C] pyruvate/[1-13C]lactate calculated from the dynamic peak intensities (p < .0001). Shaded regions represent standard error of
the mean value (n = 5 for both groups). (d) The box plot shows the total hyperpolarized 13C signal from the brain obtained for 10 s after the
injection (P < .01). (e) Hyperpolarized [1-13C]lactate/[1-13C]pyruvate ratio showed a negative correlation with total 13C signal (n = 10, Pearson’s r =
− 0.632, P < .05). (f) The ratio of [1-13C] lactate/13C-bicarbonate calculated from the peak intensity (n = 5 for both groups). Error bars represent
standard error of the mean. * p < 0.05
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The metabolite map of the brain was explored using
hyperpolarized 13C chemical shift imaging (n = 4–5 for
both groups, Fig. 3a). The [1-13C] pyruvate perfusion sig-
nal was mainly seen in veins in the retro-orbital area, sa-
gittal sinus, and transverse sinus of control mice, but the
parenchymal [1-13C] lactate signal was weak. On the
other hand, although the [1-13C] pyruvate perfusion sig-
nal was weak, the [1-13C] lactate metabolite signal was
strongly seen in the brain parenchyma of HFD-fed mice.
The highest [1-13C] lactate/[1-13C] pyruvate conversion
ratio was detected in the hippocampus and striatum.
Voxel based analysis represented that higher [1-13C] lac-
tate/[1-13C] pyruvate conversion was not only in the
brain (Fig. 3b), but also in medial temporal lobe (Fig.
3c). The blood-brain barrier (BBB) permeability could
influence [1-13C] pyruvate delivery to the brain. Thus we
assessed permeability in the brain of mice fed HFD using
dynamic contrast-enhanced (DCE)-MRI and calculated
the transfer constant (Ktrans) from blood plasma into the
extravascular-extracellular space and rate constant (Kep)
from extravascular-extracellular space back to the blood
plasma. DCE MRI showed no differences in the calcu-
lated permeability parameters, transfer constant (Fig. 4a)
and rate constant (Fig. 4b) (n = 3, for both groups). Also
the expression level of claudin-5, a blood-brain barrier
integral protein, was not different (n = 3, for both
groups; Fig. 4c).
Mice fed HFD for 6months showed decreased PDH
activity and increased lactate production
Since the signal intensity of hyperpolarized [1-13C] lac-
tate reflect the amount of lactate pool in the tissue [27],
we measured the lactate content in the brain cortex,
hippocampus, and striatum. The amount of lactate sig-
nificantly increased in the brain cortex (p < 0.01), and
striatum (p < 0.05) in HFD-fed mice (n = 5 for both
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Fig. 3 Chemical shift imaging of hyperpolarized 13C MR spectroscopy. (a) Color maps overlaid on the 1H images represent [1-13C] pyruvate and
[1-13C] lactate peak intensities, and[1-13C] lactate/[1-13C] pyruvate intensity ratios. The images were acquired for35s from 18 s after intravenous
injection of 79 mM hyperpolarized 13C-pyruvate in the coronal plane with 3.5 mm slice thickness and 1 × 1 mm2 in-plain resolution. (b) [1-13C]
lactate/[1-13C] pyruvate intensity ratios in the whole brain. (c) [1-13C] lactate/[1-13C] pyruvate intensity ratios in the Medial temporal lobe
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groups, Fig. 5a). However, the serum lactate level showed
no difference (Fig. 5b). To elucidate the cause of higher
lactate production in the brain tissue we investigated the
LDH which catalyzes the reaction between pyruvate and
lactate, and pyruvate dehydrogenase (PDH), the first step
enzyme for pyruvate oxidation in mitochondria. PDH en-
zyme activity was decreased in the cortex (p < 0.01) and
striatum (p < .001) (n = 3 for both groups, Fig. 5c). But, the
expression level of A and B subunits of LDH in the brain
tissue showed no difference (n = 5 for both groups, Fig.
5d,e), and phosphorylated PDH (Ser293) level was in-
creased in the striatum of mice fed HFD (n = 3 for both
groups, p < 0.05; Fig. 5f).
Mice fed HFD for 6months developed cognitive
impairment
Since the hippocampus is the most vulnerable area in
subjects with dementia, we performed two hippocampus
-dependent cognitive behavior test. In the Morris water
maze task, mice were allowed to learn the location of
the invisible platform for 4 consecutive days. Although
mice fed both control and HFD groups were successful
to learn the location of the hidden platform during
4-day trials, the mice fed HFD showed less efficiency in
learning the spatial memory (Fig. 6a). Furthermore, the
mice fed HFD spent equivalent time in all quadrants
with no significant differences during probe test, while
B CA
Claudin-5
Cont. HFD Cont. HFD Cont. HFD
Fig. 4 Intact blood-brain barrier function in HFD fed mice. (a) Transfer constant, (b) rate constant, and (c) cropped images of claudin-5 and the
quantified claudin-5 were by the ratio to the β-actin showed no difference (n = 3–4 for both groups)
A B C
D E F
Fig. 5 Increased lactate production and decreased pyruvate dehydrogenase (PDH) activity in HFD fed mice. (a) Amount of lactate in 40 μg of a
lysate of cortex, hippocampus and striatum tissues (n = 5 for both group). (b) Serum lactate level measured using ELISA (10.64 ± 1.745 vs. 13.02 ±
0.75; n = 10 each). (c) PDH activity measured in the cortex, hippocampus and striatum tissues (n = 5–6 for both groups). (d) Quantified LDHA by
the ratio to β-actin and cropped images (n = 5 for both groups). (e) Quantified LDHB by the ratio to β-actin and cropped images (n = 5 for both
groups). (f) Quantified Phosphorylated PDH by the ratio to total PDH and cropped images (n = 5 for both groups). * p < 0.05, ** p < 0.01,
*** p < 0.001
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mice fed ND explored the target quadrant more than
other areas, which implies that mild cognitive impair-
ment can be developed by high fat diet regimen in a
mild way (Fig. 6b, c). Therefore, to analyze the behavior
patterns of mice fed HFD sensitively, we calculated the
platform crossing number during the probe test. The
HFD-fed mice showed a decrement in crossing number
(Fig. 6d). No difference between total distances moved
indicated that HFD did not effect on locomotor activity
or motivation (Fig. 6e, f ). The object location recogni-
tion task assesses cognition, specifically spatial memory
and discrimination in rodent models of CNS disorders.
Mice fed HFD showed significantly impaired perform-
ance in the object location recognition task. The lack of
differences in preference ratio and significantly low dis-
crimination ratio were observed in mice fed HFD (n = 10
for both groups, p < 0.05; Fig. 6g, h). The result of object
recognition test might have been confounded by several
factors such as anxiety, nomophobia, and motivation or
interest of mice in interacting with objects used. How-
ever, this is unlikely for we conducted 3-days of habitu-
ation, which might minimize mice’s anxiety, and also we
found no group difference in exploration time (Fig. 6i),
which indicates general motivation to explore objects.
To estimate the relation between brain metabolism with
the congitive decline, we analyzed the correlation be-
tween hyperpolarized [1-13C] lactate/pyruate ratio in the
medial temporal lobe and time to spent in target qur-
drant during 60 s in water mazed behavior test. Hyper-
polarized [1-13C] lactate/[1-13C] pyruvate ratio showed a
negative correlation with time to spent in the target
quadrant (Additional file 1: Figure S1; n = 5, Pearson’s r
= − 0.692, p < 0.05), which implies that incrased glycoly-
sis was associated with cognitive decline.
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Mice fed HFD for 3months showed increased lactate
conversion in hyperpolarized 13C MRS without cognitive
decline
To determine metaboic alteration toward glycolysis by
HFD occur before the cognitive decline, we performed
hyperpolarized 13C MR spectroscopy in the brain of
mice fed HFD for 3 months. They showed significant
weight gain (p < 0.001, Fig. 7b) and higher fasting serum
glucose level to the control mice (n = 5 for both groups;
p < 0.001; Fig. 7c). In the Morris water maze task, both
control and HFD groups did not show the difference to
learn the location of the hidden platform during 4-day
trials (n = 5 for both groups; Fig. 7d,e). In hyperpolarized
[1-13C] pyruvate MR spectroscopy, 13C signal in the
brain, as an indicator of cerebral perfusion, did not dis-
tinguish between control and mice fed HFD (Fig. 7f ),
but the dynamic conversion ratio of hyperpolarized
[1-13C] lactate/[1-13C] pyruvate showed significantly in-
creased in the brain of HFD-fed mice (n = 4 for both
groups, p < 0.001; Fig. 7g), suggesting that increased gly-
colysis occur before cerebral hypoperfusion and cogni-
tive decline by HFD.
Discussion
In this work, we presented the early change of the pyru-
vate metabolism in the brain of an animal model fed
HFD. Increased glycolysis may cause an increased hyper-
polarized [1-13C] lactate signal. Since the increased
hyperpolarized [1-13C] lactate/[1-13C] pyruvate signal ra-
tio could represent not only the state of low oxygen ten-
sion [28, 29], but also the increased cytosolic glycolysis
without oxygen tension so called anaerobic glycolysis.
The perfusion and the metabolic conversion are the sig-
nificant factors affecting the degree of the hyperpolari-
zed13C-lactate signal [28]. As the total 13C signal can be
an indicator of perfusion [30], decreased total carbon sig-
nal corresponds to decreased cerebral perfusion. Reduced
perfusion state of the brain fed HFD for 6months in this
study is consistent with a report of decreased perfusion
state in Alzheimer’s disease patients [31]. Interestingly,
these mice fed HFD for 3months showed increased
hyperpolarized [1-13C] lactate conversion without hypo-
perfusion. On the other hand, mice fed HFD for 6months
showed decreased cerebral perfusion and a negative cor-
relation between the perfusion and the hyperpolarized
[1-13C] lactate/[1-13C] pyruvate ratio. Those results sug-
gest that increased glycolysis may be an earlier metabolic
alteration and cerebral hypoperfusion by long-term expos-
ure to HFD may further promote to be converted to lac-
tate as a consequence of tissue hypoxia [32].
Recently an MR spectroscopy study using [1-13C] glu-
cose reported an age-dependent change of glucose me-
tabolism in a triple transgenic (3xTG) Alzheimer’s
disease mouse model. In 7-month mice, brain metabol-
ism increased, while it decreased in 13-month mice [33,
34]. According to the FDG-PET study in this 3xTG mice,
FDG uptake significantly decreased in the almost the
whole brain of 18-month mice, but decreased in the spe-
cial region containing cingulate gyrus of 12-month mice
[35]. Those results suggest that alteration toward to gly-
colysis may be an earlier metabolic event than decreased
glucose metabolism shown in FDG-PET imaging and
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therefore hyperpolarized [1-13C] pyruvate MR spectros-
copy have a potential to monitor earlier disease process.
Hyperpolarized 13C MR spectroscopy showed the
highest [1-13C] lactate/[1-13C] pyruvate signal ratio not
only in the hippocampus known as the particularly af-
fected in Alzheimer’s disease [36], but also in stratum in
mice fed HFD for 6months. Memories of hippocampal
and striatal systems are thought to operate independ-
ently and to support place-based learning under the con-
trol of the hippocampus, and response-based learning
under the control of the striatum [37]. On the other
hand, a report showed impairment of place learning
memory in the dorsomedial striatal injury [38]. The
other report using water maze based spatial memory test
showed dorsomedial striatum was activated during early
learning and getting inactivated during late learning, and
this pattern was also observed in human [39], suggesting
the importance of striatum in learning memory.
Studies on the relationship between lactate level and
cognition in the brain have been reported. Lactate
amount in frontal cortex and interstitial fluid of the
hippocampus was elevated in APP/PS1 transgenic mice
having cognitive decline [40]. In human studies, in-
creased lactate level was reported in the cerebrospinal
fluid of Alzheimer’s disease patients [41], and it showed
a negative correlation with memory performance in indi-
viduals with mild cognitive impairment [42]. Further-
more, it has been reported that acute hyperglycemia
increased lactate and amyloid beta in the hippocampal
interstitial fluid and that suggest increased glucose me-
tabolism regulates neuronal activity via KATP channel in
APP/PS1 mice [43]. However, it is mostly unknown
whether enhanced lactate production is beneficial or
harmful to memory function.
In early onset Alzheimer’s disease, genetic factors such
as amyloid precursor protein, or preseniline(PSEN) 1 or
2 has been regarded as dominant factors, but in late on-
set Alzheimer’s disease(LOAD) environmental factor
such as metabolic disease has been regarded to induce
Alzheimer’s pathogenesis. Genetically in LOAD, the apo-
lipoprotein E(APOE) gene is the strong factor to cogni-
tive decline. APOE gene has the three polymorphism-
ε2, ε3, and ε4. Among them, almost 40% of patients hav-
ing Alzheimer’s disease have ApoE ε4 alleles [44]. Ac-
cording to the animal study, mice having ApoE ε3 and
ε4 did not show distinguishable cognitive decline based
on water maze behavior task, but when fed HFD for 6
months, mice having ApoE ε4 showed significant cogni-
tive decline compared to mice having ApoE ε3 fed HFD,
representing the importance of the brain metabolism as
an environment factor to the cognition [45]. Recently, the
importance of lactate to cognitive function has been re-
ported that lactate delivered from glia via gial-neuron
lactate shuttle and used as a fuel for neuronal lipid
production and this lipid in a neuron are transported to
glia via ApoE. Since ApoE ε4 has less efficacy to transport
lipid, inability to transport lipid to glia leads to neurode-
generation [46]. Those results show the possibility that al-
tered metabolic alteration toward glycolysis promotes
lipid synthesis in neuron and induces neurodegeneration.
In the present study, we investigatedthe pyruvate me-
tabolism of the brain in an HFD-fed mouse model using
the multimodal imaging and in conjunction with the
biochemical assay and the behavior test. Our results sug-
gest that the increased hyperpolarized [1-13C] lactate sig-
nal in the brain of HFD-fed mice represent that altered
metabolic alteration toward to glycolysis and hypoperfu-
sion by the long-term metabolic stress by HFD further
promote to glycolysis. Increased pyruvate to lactate con-
version was prominent in the hippocampus and striatum
which was a vulnerable area to cognitive impairment. In-
creased lactate signal from the brain on the hyperpolar-
ized [1-13C] pyruvate MR spectroscopy could be an early
sign to suggest cognitive impairment.
Additional file
Additional file 1: Figure S1. Hyperpolarized [1-13C]lactate/[1-
13C]pyruvate ratio in medial temporal lobe showed a negative
correlation with time to spent in the target quadrant (n = 9, Pearson’s r =
− 0.692, P < .05). (PPTX 47 kb)
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